GRASP: Getting it Right: Addressing Shoulder Pain. Clinical and cost effectiveness of progressive exercise compared to best practice advice, with or without corticosteroid injection, for the treatment of rotator cuff disorders: a 2x2 factorial randomised controlled trial - The GRASP Trial

niversity of Oxford0 个研究点目标入组 704 人开始时间: 2016年10月17日最近更新: 2020年10月13日

适应症

试验速览

暂无简介。

•1) Men and women aged 18 years and above;
•2) with a new episode of shoulder pain (i.e., within the last 6 months) attributable to a rotator cuff disorder (e.g., cuff tendonitis, impingement syndrome, tendinopathy or rotator cuff tear) using the diagnostic criteria set out in the BESS (British Shoulder and Elbow Society) guidelines;
•3) who are not currently receiving physiotherapy;
•4) who are not being considered for surgery; and
•5) able to understand spoken and written English.
•Are the trial subjects under 18? no
•Number of subjects for this age range: 0
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 600
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 104

•1) Participants with a history of significant shoulder trauma (e.g., dislocation, fracture or full thickness tear requiring surgery);
•2) those with a neurological disease affecting the shoulder;
•3) those with other shoulder disorders (e.g., inflammatory arthritis, frozen shoulder, glenohumeral joint instability) or with red flags consistent with the criteria set out in the BESS guidelines;
•4) those who have received corticosteroid injection or physiotherapy for shoulder pain in the last 6 months; and
•5) those with contra-indications to corticosteroid injection.

发起方